Iconovo, a Swedish inhalation device company, prides itself for being able to provide a wide range of generic inhalation devices and associated drug formulations. They boast a broad product portfolio and strong patent strategy granting the company good product protection. Last week, Iconovo took yet another step forward in strengthening its patent portfolio when it learned that the European Patent Office intends to grant a patent for the company’s single-dose dry powder inhaler – ICOone.
Read the full article at biostock.se:
https://www.biostock.se/2020/04/iconovo-utokar-patentskyddet-for-icoone/
This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se
